关注
Prasanna Srinivasan Ramalingam
Prasanna Srinivasan Ramalingam
Research Associate
在 vit.ac.in 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
A Comprehensive Review on Ocimum basilicum
B Purushothaman, RP Srinivasan, P Suganthi, B Ranganathan, J Gimbun, ...
Journal of Natural Remedies, 71-85, 2018
1802018
Lipid peroxidation and anti-obesity activity of Nigella sativa seeds
P Srinivasan Ramalingam, MAS Raj, P Ravichandran, K Shanmugam, ...
World J. Pharm. Res 6, 882-892, 2017
172017
N-acetyl l-aspartate and Triacetin modulate tumor suppressor MicroRNA and class I and II HDAC gene expression induce apoptosis in Glioblastoma cancer cells in vitro
JR Mekala, RK Kurappalli, PS Ramalingam, NR Moparthi
Life sciences 286, 120024, 2021
142021
Distinctive pharmacological activities of Eclipta abla and its coumestan wedelolactone
P Balakrishnan, GK Sekar, PS Ramalingam, S Nagarasan, V Murugesan, ...
Indo American Journal of Pharmaceutical Sciences 5 (4), 2996-3002, 2018
132018
Synthesis, in vitro and structural aspects of cap substituted Suberoylanilide hydroxamic acid analogs as potential inducers of apoptosis in Glioblastoma cancer cells via HDAC …
JR Mekala, PS Ramalingam, S Mathavan, RBRD Yamajala, NR Moparthi, ...
Chemico-biological interactions 357, 109876, 2022
112022
Isolation and characterisation of cellulolytic activity of bacteria and fungi from the soil of paper recycling unit at periyar maniammai university
KJ Saranya, P Balakrishnan, PS Ramalingam, S Parthasarathi, ...
Indo Ame J Pharma Res 7 (6), 8253-8264, 2017
102017
Identification of dietary bioflavonoids as potential inhibitors against KRAS G12D mutant—novel insights from computer-aided drug discovery
PS Ramalingam, P Balakrishnan, S Rajendran, A Jothi, R Ramalingam, ...
Current Issues in Molecular Biology 45 (3), 2136-2156, 2023
72023
Potential Biomarkers Uncovered by Bioinformatics Analysis in Sotorasib Resistant-Pancreatic Ductal Adenocarcinoma
PS Ramalingam, A Priyadharshini, AE Isaac, S Arumugam
Frontiers in Medicine 10, 836, 2023
42023
ROS Modulatory Role of HDAC Inhibitors in Cancer Cells: A Systemic Approach
JR Mekala, PS Ramalingam, NR Moparthi, VK Kutala
Handbook of Oxidative Stress in Cancer: Therapeutic Aspects, 1-28, 2022
42022
Reverse vaccinology and immunoinformatics approaches to design multi-epitope based vaccine against oncogenic KRAS
PS Ramalingam, S Arumugam
Medical Oncology 40 (10), 283, 2023
32023
A green one-pot synthetic protocol of hexahydropyrimido[4,5-d]pyrimidin-4(1H)-one derivatives: molecular docking, ADMET, anticancer and antimicrobial studies
HD Trivedi, BY Patel, SD Hadiyal, G Italiya, PS Ramalingam
Molecular Diversity 28 (1), 183-195, 2024
12024
Nigella Sativa L.–A Note on Phytochemistry, Extraction, Pharmacological Activities, and Therapeutic Utility
PS Ramalingam, RAK Mishra, JR Mekala, KM Gothandam, S Arumugam
Pharmacological Aspects of Essential Oils, 243-264, 2024
12024
Computational design and validation of effective siRNAs to silence oncogenic KRAS
PS Ramalingam, S Arumugam
3 Biotech 13 (11), 350, 2023
12023
Synthesis of 8-methyl-2-phenylquinazolin-4 (3H)-ones derived Schiff's bases: Spectroscopic properties, SAR, docking approaches and their anticancer and antimicrobial activity
N Ramani, BY Patel, G Italiya, PS Ramalingam, R Mishra, S Subramanian, ...
Journal of Molecular Structure 1310, 138256, 2024
2024
Liver X receptors (LXRs) in Cancer-An Eagle's View on Molecular Insights and Therapeutic Opportunities
PS Ramalingam, S Elangovan, JR Mekala, S Arumugam
Frontiers in Cell and Developmental Biology 12, 1386102, 2024
2024
Structural insights and functional aspects of phospholipase A2 and phospholipase D in cancer therapy
JR Mekala, S Chamarthy, PS Ramalingam, H Angirekula, VK Kutala
Phospholipases in Physiology and Pathology, 413-432, 2023
2023
High Glucose modulates the cancer cell fate by regulation of mTOR-HDAC-microRNA axis
MJ RAMAIAH, KR Kumar, RP Srinivasan, NR Moparthi, R Reddy, ...
2022
系统目前无法执行此操作,请稍后再试。
文章 1–17